Lv1
46 积分 2020-06-22 加入
Emerging frontiers in biomedicine: a bibliometric analysis of gallium-based nanomaterials
1个月前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
3个月前
已完结
Liver Failure After Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma and Ascites
6个月前
已完结
皖公网安备34019202002308
